OBJECTIVE: To describe the development and assessment of the Abbreviated Fine Severity Score (AFSS), a simplified version of the Pneumonia Severity Index (PSI) suitable for providing risk-adjusted reports to clinicians caring for patients hospitalized with community-acquired pneumonia. STUDY DESIGN: Retrospective cohort study. METHODS: We defined the AFSS based on data available in administrative and laboratory databases. We downloaded and linked these hospitalization and laboratory data from 2 cohorts (11,030 patients and 6147 patients) hospitalized with community-acquired pneumonia in all Kaiser Permanente Medical Care Program hospitals in northern California. We then assessed the relationship between the AFSS and mortality, length of stay, intensive care unit admission, and the use of assisted ventilation. Using logistic regression analysis, we assessed the performance of the AFSS and determined the area under the receiver operating characteristic curve (c statistic). Using a combination of manual and electronic medical record review, we compared the AFSS with the full PSI in 2 subsets of patients in northern California and Denver, Colorado, whose medical records were manually reviewed. RESULTS: The AFSS compares favorably with the PSI with respect to predicting mortality. It has good discrimination with respect to inhospital (c = 0.74) and 30-day (c = 0.75) mortality. It also correlates strongly with the PSI (r = 0.87 and r = 0.93 in the 2 medical record review subsets). CONCLUSIONS: The AFSS can be used to provide clinically relevant risk-adjusted outcomes reports to clinicians in an integrated healthcare delivery system. It is possible to apply risk-adjustment methods from research settings to operational ones.
OBJECTIVE: To describe the development and assessment of the Abbreviated Fine Severity Score (AFSS), a simplified version of the Pneumonia Severity Index (PSI) suitable for providing risk-adjusted reports to clinicians caring for patients hospitalized with community-acquired pneumonia. STUDY DESIGN: Retrospective cohort study. METHODS: We defined the AFSS based on data available in administrative and laboratory databases. We downloaded and linked these hospitalization and laboratory data from 2 cohorts (11,030 patients and 6147 patients) hospitalized with community-acquired pneumonia in all Kaiser Permanente Medical Care Program hospitals in northern California. We then assessed the relationship between the AFSS and mortality, length of stay, intensive care unit admission, and the use of assisted ventilation. Using logistic regression analysis, we assessed the performance of the AFSS and determined the area under the receiver operating characteristic curve (c statistic). Using a combination of manual and electronic medical record review, we compared the AFSS with the full PSI in 2 subsets of patients in northern California and Denver, Colorado, whose medical records were manually reviewed. RESULTS: The AFSS compares favorably with the PSI with respect to predicting mortality. It has good discrimination with respect to inhospital (c = 0.74) and 30-day (c = 0.75) mortality. It also correlates strongly with the PSI (r = 0.87 and r = 0.93 in the 2 medical record review subsets). CONCLUSIONS: The AFSS can be used to provide clinically relevant risk-adjusted outcomes reports to clinicians in an integrated healthcare delivery system. It is possible to apply risk-adjustment methods from research settings to operational ones.
Authors: Vincent X Liu; Vikram Fielding-Singh; John D Greene; Jennifer M Baker; Theodore J Iwashyna; Jay Bhattacharya; Gabriel J Escobar Journal: Am J Respir Crit Care Med Date: 2017-10-01 Impact factor: 21.405
Authors: Alejandro Schuler; David A Wulf; Yun Lu; Theodore J Iwashyna; Gabriel J Escobar; Nigam H Shah; Vincent X Liu Journal: Crit Care Med Date: 2018-06 Impact factor: 7.598
Authors: Vincent X Liu; Efren Rosas; Judith Hwang; Eric Cain; Anne Foss-Durant; Molly Clopp; Mengfei Huang; Derrick C Lee; Alex Mustille; Patricia Kipnis; Stephen Parodi Journal: JAMA Surg Date: 2017-07-19 Impact factor: 14.766
Authors: Vincent X Liu; John W Morehouse; Jennifer M Baker; John D Greene; Patricia Kipnis; Gabriel J Escobar Journal: J Hosp Med Date: 2016-11 Impact factor: 2.960
Authors: Alison E Fohner; John D Greene; Brian L Lawson; Jonathan H Chen; Patricia Kipnis; Gabriel J Escobar; Vincent X Liu Journal: J Am Med Inform Assoc Date: 2019-12-01 Impact factor: 4.497
Authors: Kelly C Vranas; Jeffrey K Jopling; Timothy E Sweeney; Meghan C Ramsey; Arnold S Milstein; Christopher G Slatore; Gabriel J Escobar; Vincent X Liu Journal: Crit Care Med Date: 2017-10 Impact factor: 7.598
Authors: Josh Hanson; Sue J Lee; Sanjib Mohanty; M A Faiz; Nicholas M Anstey; Prakaykaew Charunwatthana; Emran Bin Yunus; Saroj K Mishra; Emiliana Tjitra; Ric N Price; Ridwanur Rahman; Francois Nosten; Ye Htut; Gofranul Hoque; Tran Thi Hong Chau; Nguyen Hoan Phu; Tran Tinh Hien; Nicholas J White; Nicholas P J Day; Arjen M Dondorp Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: Phyo Kyaw Myint; Chun Shing Kwok; Sumit R Majumdar; Dean T Eurich; Allan B Clark; Pedro P España; Shin Yan Man; David T Huang; Donald M Yealy; Derek C Angus; Alberto Capelastegui; Timothy H Rainer; Thomas J Marrie; Michael J Fine; Yoon K Loke Journal: BMJ Open Date: 2012-05-21 Impact factor: 2.692